Amy Raskopf | Head, IR |
Saundra Pelletier | President, CEO & Director |
Jay File | CFO |
Russell Barrans | Chief Commercial Officer |
Kelly Culwell | Chief Medical Officer |
Jeffrey Hung | Morgan Stanley |
Annabel Samimy | Stifel Financial Corp. |
Raghuram Selvaraju | H.C. Wainwright & Co. |
David Amsellem | Piper Sandler & Co. |
Disclaimer: *NEW* We are providing this transcript version in a raw | machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. |
[00:00:04] Ladies and gentlemen, thank you for standing by and welcome to the Evofem Biosciences the third quarter twenty twenty financial results conference call at this time of participants are in listen only mode. After the speakers presentation, there would be a question and answer session to participate in that portion of the call.
You will need to press that one on your telephone. Please be advised that today's conference may be recorded if you require any further assistance with Pakistan and to. I will now have the conference over to your speaker today.